Improving the outcome of established therapies for osteoporosis by adding the active D-hormone analog alfacalcidol J. D. RingeE. Schacht Review 01 August 2007 Pages: 103 - 111
Antigen specificity of antihistone antibodies in connective tissue disease patients with anti-U1RNP antibodies Takamasa WayakuMinoru HasegawaShinichi Sato Original Article 13 July 2007 Pages: 113 - 119
Tumor necrosis factor alpha −308 polymorphism is associated with rheumatoid arthritis in Han population of Eastern China Ruiwen ChenMeng FangShuhan Sun Original Article 21 August 2007 Pages: 121 - 126
EGF activates PI3K-Akt and NF-κB via distinct pathways in salivary epithelial cells in Sjögren’s syndrome Hideki NakamuraAtsushi KawakamiKatsumi Eguchi Original Article 20 July 2007 Pages: 127 - 136
Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis Yasunori KageyamaTetsuya IchikawaAkira Nagano Original Article 10 July 2007 Pages: 137 - 143
Microvascular dysfunction in rheumatoid arthritis assessed by laser Doppler anemometry: relationship to soluble adhesion molecules and extraarticular manifestations Martin F. MeyerOlga SchmidtJürgen Braun Original Article 29 June 2007 Pages: 145 - 152
Safety and efficacy of once-weekly application of Etanercept in children with juvenile idiopathic arthritis Jasmin B. Kuemmerle-DeschnerGerd Horneff Original Article 20 July 2007 Pages: 153 - 156
Measurement of advanced glycation endproducts in skin of patients with rheumatoid arthritis, osteoarthritis, and dialysis-related spondyloarthropathy using non-invasive methods Tomoko MatsumotoToshiyuki TsurumotoToshio Miyata Original Article 25 July 2007 Pages: 157 - 160
The association of DRB1*04 share epitope alleles and tumor necrosis factor-alpha gene polymorphism (−863) with susceptibility to rheumatoid arthritis in Thai N. HirankarnJ. NakkuntodP. Charoenwongse Original Article 23 June 2007 Pages: 161 - 165
A novel mutation of the familial Mediterranean fever gene in a Greek family related to a non-classical, variably expressed FMF phenotype Dimitrios ZoniosClio P. MavraganiKonstatinos Ritis Case Report 27 June 2007 Pages: 167 - 169
Antiphospholipid syndrome: a predisposing factor for early onset HELLP syndrome Panagiotis TsirigotisGeorge MantziosJohn Dervenoulas Case Report 19 June 2007 Pages: 171 - 174
Successful treatment with rituximab in a patient with mental nerve neuropathy in primary Sjögren’s syndrome Pascal SèveEmilie GachonChristiane Broussolle Case Report 20 July 2007 Pages: 175 - 177
Successful rituximab-CHOP treatment of systemic lupus erythematosus associated with diffuse large B-cell non-Hodgkin lymphoma Zs. SimonT. TarrA. Illes Case Report 17 August 2007 Pages: 179 - 183
Hodgkin’s lymphoma following treatment with etanercept in ankylosing spondylitis Kenan AksuAyhan DonmezEker Doganavsargil Case Report 11 July 2007 Pages: 185 - 187
Tumour necrosis factor a −308 promoter polymorphism in patients with rheumatoid arthritis Zahra RezaieyazdiJalil Tavakol AfshariFarnaz Mohajer Preliminary Results 29 August 2007 Pages: 189 - 191
A probe into the HLA-DR and DQ of Arab patients with primary antiphospholipid (Hughes) syndrome Haider M. Al AttiaAnitha Santhosh Short Communication 04 July 2007 Pages: 193 - 195
TNF inhibitors for ankylosing spondylitis in the real world Claire M. McVeighAubrey L. BellAndrew P. Cairns Letter to the Editor 30 June 2007 Pages: 199 - 200
Successful treatment with infliximab of refractory rheumatoid arthritis in a male with ‘GDF5 brachydactyly’ Takeshi SuzukiZen-ichiro Honda Letter to the Editor 30 June 2007 Pages: 201 - 203
